Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Emerg Microbes Infect ; 12(1): 2164742, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-36591809

RESUMO

Viral envelope glycoproteins are crucial for viral infections. In the process of enveloped viruses budding and release from the producer cells, viral envelope glycoproteins are presented on the viral membrane surface as spikes, promoting the virus's next-round infection of target cells. However, the host cells evolve counteracting mechanisms in the long-term virus-host co-evolutionary processes. For instance, the host cell antiviral factors could potently suppress viral replication by targeting their envelope glycoproteins through multiple channels, including their intracellular synthesis, glycosylation modification, assembly into virions, and binding to target cell receptors. Recently, a group of studies discovered that some host antiviral proteins specifically recognized host proprotein convertase (PC) furin and blocked its cleavage of viral envelope glycoproteins, thus impairing viral infectivity. Here, in this review, we briefly summarize several such host antiviral factors and analyze their roles in reducing furin cleavage of viral envelope glycoproteins, aiming at providing insights for future antiviral studies.


Assuntos
COVID-19 , Ebolavirus , HIV-1 , Doença pelo Vírus Ebola , Viroses , Humanos , Furina/metabolismo , Proteínas do Envelope Viral/metabolismo , SARS-CoV-2/metabolismo , Antivirais/farmacologia , Glicoproteínas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA